Other Events ·
Amgen Inc. disclosed a material cybersecurity incident in July 2026 involving unauthorized access to data stored in…
AMGNAmgen Inc
Amgen Inc. disclosed a material cybersecurity incident in July 2026 involving unauthorized access to data stored in third-party cloud environments. The company confirmed that proprietary data, patient protected health information (PHI), and other sensitive information were exfiltrated. Amgen activated its response plan, implemented containment measures, and engaged independent forensic experts. While the investigation remains ongoing, the company stated there is no impact on products, manufacturing operations, or financial reporting systems. The incident was deemed material due to the volume of files and sensitivity of the data, though it is not expected to materially affect financial condition or results of operations. Amgen Inc. operates in the biotechnology industry, developing and commercializing human therapeutics.